Q73368 (POL_HV1B9) Human immunodeficiency virus type 1 group M subtype B (strain 896)(HIV-1)
Gag-Pol polyprotein UniProtKBInterProInteractive Modelling
1435 aa; Sequence (Fasta)
Molecule Processing
| Matrix protein p17 | |
| Capsid protein p24 | |
| Nucleocapsid protein p7 | |
| p6-pol | |
| Protease | |
| Reverse transcriptase/ribonuclease H | |
| p51 RT | |
| p15 | |
| Integrase |
It is possible new templates exist for this target since these models were created.
Sequence Features
| 513 | For protease activity; shared with dimeric partner | ||
| 697 | Magnesium; catalytic; for reverse transcriptase activity | ||
| 772 | Magnesium; catalytic; for reverse transcriptase activity | ||
| 773 | Magnesium; catalytic; for reverse transcriptase activity | ||
| 1030 | Magnesium; catalytic; for RNase H activity | ||
| 1065 | Magnesium; catalytic; for RNase H activity | ||
| 1085 | Magnesium; catalytic; for RNase H activity | ||
| 1136 | Magnesium; catalytic; for RNase H activity | ||
| 1211 | Magnesium; catalytic; for integrase activity | ||
| 1263 | Magnesium; catalytic; for integrase activity | ||
| 1299 | Magnesium; catalytic; for integrase activity | ||
| 988 | Essential for RT p66/p51 heterodimerization | ||
| 1001 | Essential for RT p66/p51 heterodimerization | ||
| 390-407 | CCHC-type 1 | ||
| 411-428 | CCHC-type 2 | ||
| 1150-1191 | Integrase-type | ||
| 1370-1417 | Integrase-type | ||
| 132-133 | Cleavage; by viral protease | ||
| 221-222 | Cis/trans isomerization of proline peptide bond; by human PPIA/CYPA | ||
| 363-364 | Cleavage; by viral protease | ||
| 377-378 | Cleavage; by viral protease | ||
| 432-433 | Cleavage; by viral protease | ||
| 440-441 | Cleavage; by viral protease | ||
| 488-489 | Cleavage; by viral protease | ||
| 587-588 | Cleavage; by viral protease | ||
| 1027-1028 | Cleavage; by viral protease; partial | ||
| 1147-1148 | Cleavage; by viral protease | ||
| 2-132 | Immunodeficiency lentiviral matrix, N-terminal IPR000071PF00540 | ||
| 149-349 | Retroviral nucleocapsid protein Gag, p24 fragment IPR000721PF00607 | ||
| 391-406 | Zinc finger, CCHC-type IPR001878PF00098 | ||
| 412-428 | Zinc finger, CCHC-type IPR001878PF00098 | ||
| 494-585 | Retropepsins IPR018061PF00077 | ||
| 650-819 | Reverse transcriptase domain IPR000477PF00078 | ||
| 829-890 | Reverse transcriptase thumb IPR010661PF06817 | ||
| 905-1006 | Reverse transcriptase connection IPR010659PF06815 | ||
| 1025-1143 | Ribonuclease H domain IPR002156PF00075 | ||
| 1155-1191 | Integrase, N-terminal zinc-binding domain IPR003308PF02022 | ||
| 1205-1292 | Integrase, catalytic core IPR001584PF00665 | ||
| 1372-1415 | Integrase, C-terminal, retroviral IPR001037PF00552 |
Sequence Alignments
Capsid protein p24 133-363; PRO_0000250974
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | -0.20 | 4xfy.1.B | 97.40 | ||
| Assess | |||||
| monomer | -0.74 | 2m8n.1.A | 97.40 | ||
| Assess | |||||
| monomer | -0.58 | 2m8l.1.B | 97.40 | ||
| Assess | |||||
Reverse transcriptase/ribonuclease H 588-1147; PRO_0000250980
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | 0.93 | 4zhr.1.A | 96.79 | ||
| Assess | |||||
| monomer | -2.60 | 2jle.1.B | 96.29 | ||
| Assess | |||||
p51 RT 588-1027; PRO_0000250981
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | -2.60 | 2jle.1.B | 96.29 | ||
| Assess | |||||
Integrase 1148-1435; PRO_0000250983
| Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|
| monomer | 1×ZN; | -1.12 | 6rwl.1.B | 76.04 | |
| Assess | |||||
| monomer | 1×ZN; | -0.24 | 6rwl.1.A | 76.04 | |
| Assess | |||||
| monomer | 1×ZN; | -0.69 | 5u1c.1.A | 95.92 | |
| Assess | |||||
| monomer | -1.03 | 5u1c.1.B | 95.92 | ||
| Assess | |||||